In:
Alzheimer's & Dementia, Wiley, Vol. 5, No. 4 ( 2009-07), p. 307-317
Abstract:
New marker‐based criteria for the diagnosis of Alzheimer's disease (AD) were recently proposed. We describe their operational translation in 144 consecutive patients referred to our Memory Clinic. Methods Visual ratings of hippocampal atrophy and of cortical glucose hypometabolism in magnetic resonance imaging and positron emission tomography, and concentrations of total tau and Aβ1‐42 in cerebrospinal fluid were assessed in 12 patients with subjective memory complaints (SMCs) (Mini‐Mental State Examination [MMSE] score, 28.0 ± 1.1 [mean ± SD] ), 37 with mild cognitive impairment (MCI) (MMSE, 25.1 ± 3.6), 55 with AD (MMSE, 21.1 ± 3.5), and 40 with non‐AD dementia (MMSE, 21.6 ± 5.5). Results The sensitivity for AD of each individual biomarker was higher (65% to 87%) than for MCI (18% to 50%). Each biomarker's specificity for SMC and non‐AD dementias was good to moderate (83% and 53%). Positivity for at least one marker increased the probability 38 times of belonging to the AD group ( P 〈 0.0001). Conclusion The new diagnostic criteria can be operationalized in clinical routines, but longitudinal studies of MCI patients will need to assess the criteria's prognostic value.
Type of Medium:
Online Resource
ISSN:
1552-5260
,
1552-5279
DOI:
10.1016/j.jalz.2009.04.1235
Language:
English
Publisher:
Wiley
Publication Date:
2009
detail.hit.zdb_id:
2201940-6